Safety and Tolerability of the Protein C Activator AB002 in End-Stage Renal Disease Patients on Hemodialysis: a Randomized Phase 2 Trial.Norah G. Verbout,Christina U. Lorentz,Brandon D. Markway,Michael Wallisch,Thomas C. Marbury,Enrico Di Cera,Joseph J. Shatzel,Andras Gruber,Erik I. TuckerCOMMUNICATIONS MEDICINE（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
